ALP Pharm Beijing

Beijing-based API company founded in 2002 that develops peptide APIs and, since 2007, has had them manufactured in partner facilities rather than a plant of its own. Holds active US Drug Master Files for bivalirudin, cetrorelix, difelikefalin, eptifibatide, exenatide, goserelin, lanreotide, leuprolide, liraglutide, octreotide, plecanatide, semaglutide, teduglutide and tirzepatide API. No FDA inspection is recorded under its own name, so ask which partner facility makes your API.

Directory assessment: ALP Pharm Beijing is listed as a manufacturer in the peptide supply chain, serving Asia markets from China (Beijing). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.